130 related articles for article (PubMed ID: 34180767)
1. Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality.
Stahl M; Narendra V; Jee J; Derkach A; Maloy M; Geyer MB; Mato AR; Roeker LE; Tallman MS; Shah GL; Daniyan A; Goldberg AD
Leuk Lymphoma; 2021 Aug; 62(8):1940-1948. PubMed ID: 34180767
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
Palanques-Pastor T; Megías-Vericat JE; Martínez P; López Lorenzo JL; Cornago Navascués J; Rodriguez Macias G; Cano I; Arnan Sangerman M; Vidriales Vicente MB; Algarra Algarra JL; Foncillas MÁ; Herrera P; Botella Prieto C; Vives S; Figuera Álvarez Á; Cuevas Palomares L; Sobas M; Contento Gonzalo A; Cuello García R; Amutio Diez ME; De Miguel Llorente D; Navas Elorza B; Bergua Burgues JM; Bernal Del Castillo T; Mateos Rodríguez MC; de Cabo López E; Franco Villegas AC; García Boyero R; Escolano Escobar C; Seri Merino C; Cervero C; Roldán Pérez A; Hermosín Ramos L; Cervera Calvo M; Olave MT; Villafuerte Gutiérrez P; de Laiglesiai A; Serrano J; Najera Irazu MJ; Piñana JL; Sanz MÁ; Martínez-López J; Montesinos P
Leuk Lymphoma; 2021 Dec; 62(12):2928-2938. PubMed ID: 34292118
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
5. Impact of SARS-CoV-2 infection on patients with hematological malignancies: a retrospective study.
Zhao H; He Y; Li Z; Huang Y; Ying Y; Huang Z
Hematology; 2023 Dec; 28(1):2288480. PubMed ID: 38063157
[TBL] [Abstract][Full Text] [Related]
6. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
[TBL] [Abstract][Full Text] [Related]
7. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Marchesi F; Salmanton-García J; Emarah Z; Piukovics K; Nucci M; López-García A; Ráčil Z; Farina F; Popova M; Zompi S; Audisio E; Ledoux MP; Verga L; Weinbergerová B; Szotkovski T; Da Silva MG; Fracchiolla N; De Jonge N; Collins G; Marchetti M; Magliano G; García-Vidal C; Biernat MM; Van Doesum J; Machado M; Demirkan F; Al-Khabori M; Žák P; Víšek B; Stoma I; Méndez GA; Maertens J; Khanna N; Espigado I; Dragonetti G; Fianchi L; Del Principe MI; Cabirta A; Ormazabal-Vélez I; Jaksic O; Buquicchio C; Bonuomo V; Batinić J; Omrani AS; Lamure S; Finizio O; Fernández N; Falces-Romero I; Blennow O; Bergantim R; Ali N; Win S; Van Praet J; Tisi MC; Shirinova A; Schönlein M; Prattes J; Piedimonte M; Petzer V; Navrátil M; Kulasekararaj A; Jindra P; Sramek J; Glenthøj A; Fazzi R; De Ramón-Sánchez C; Cattaneo C; Calbacho M; Bahr NC; El-Ashwah S; Cordoba R; Hanakova M; Zambrotta G; Sciumè M; Booth S; Rodrigues RN; Sacchi MV; García-Poutón N; Martín-González JA; Khostelidi S; Gräfe S; Rahimli L; Ammatuna E; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Cornely OA; Pagano L;
Haematologica; 2023 Jan; 108(1):22-33. PubMed ID: 35545919
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters.
Almuqrin AM; Alotaibi BA; Aldali JA; Alshalani A; AlSudais H; Aldali HJ
BMC Infect Dis; 2024 Jun; 24(1):576. PubMed ID: 38862891
[TBL] [Abstract][Full Text] [Related]
11. Could COVID-19 induce remission of acute leukemia?
Kandeel EZ; Refaat L; Abdel-Fatah R; Samra M; Bayoumi A; Abdellateif MS; Abdel-Hady H; Ali M; Khafagy M
Hematology; 2021 Dec; 26(1):870-873. PubMed ID: 34719343
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
13. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
14. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C
JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
[TBL] [Abstract][Full Text] [Related]
18. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Grivas P; Khaki AR; Wise-Draper TM; French B; Hennessy C; Hsu CY; Shyr Y; Li X; Choueiri TK; Painter CA; Peters S; Rini BI; Thompson MA; Mishra S; Rivera DR; Acoba JD; Abidi MZ; Bakouny Z; Bashir B; Bekaii-Saab T; Berg S; Bernicker EH; Bilen MA; Bindal P; Bishnoi R; Bouganim N; Bowles DW; Cabal A; Caimi PF; Chism DD; Crowell J; Curran C; Desai A; Dixon B; Doroshow DB; Durbin EB; Elkrief A; Farmakiotis D; Fazio A; Fecher LA; Flora DB; Friese CR; Fu J; Gadgeel SM; Galsky MD; Gill DM; Glover MJ; Goyal S; Grover P; Gulati S; Gupta S; Halabi S; Halfdanarson TR; Halmos B; Hausrath DJ; Hawley JE; Hsu E; Huynh-Le M; Hwang C; Jani C; Jayaraj A; Johnson DB; Kasi A; Khan H; Koshkin VS; Kuderer NM; Kwon DH; Lammers PE; Li A; Loaiza-Bonilla A; Low CA; Lustberg MB; Lyman GH; McKay RR; McNair C; Menon H; Mesa RA; Mico V; Mundt D; Nagaraj G; Nakasone ES; Nakayama J; Nizam A; Nock NL; Park C; Patel JM; Patel KG; Peddi P; Pennell NA; Piper-Vallillo AJ; Puc M; Ravindranathan D; Reeves ME; Reuben DY; Rosenstein L; Rosovsky RP; Rubinstein SM; Salazar M; Schmidt AL; Schwartz GK; Shah MR; Shah SA; Shah C; Shaya JA; Singh SRK; Smits M; Stockerl-Goldstein KE; Stover DG; Streckfuss M; Subbiah S; Tachiki L; Tadesse E; Thakkar A; Tucker MD; Verma AK; Vinh DC; Weiss M; Wu JT; Wulff-Burchfield E; Xie Z; Yu PP; Zhang T; Zhou AY; Zhu H; Zubiri L; Shah DP; Warner JL; Lopes G
Ann Oncol; 2021 Jun; 32(6):787-800. PubMed ID: 33746047
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
20. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D
J Hematol Oncol; 2020 Jul; 13(1):94. PubMed ID: 32664919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
